BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33376538)

  • 1. Identification of
    Wang K; Wu Z; Si Y; Tang W; Xu X; Cheng Y; Lin J
    Oncol Lett; 2021 Feb; 21(2):105. PubMed ID: 33376538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validation and clinical significance of LPCAT1 down-regulation in acute myeloid leukemia.
    Chen Q; Xu Z; Lin J; Deng Z; Qian J; Qian W
    Mol Biol Rep; 2023 Jun; 50(6):4955-4963. PubMed ID: 37079124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic Significance of
    Liu Y; Liu YJ; Yang L; Zhang Y; Zhang DF; Jiang ZX; Wang C; Liu YF; Wang SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):64-70. PubMed ID: 36765478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation.
    Gu Y; Chu MQ; Xu ZJ; Yuan Q; Zhang TJ; Lin J; Zhou JD
    BMC Med Genomics; 2022 Feb; 15(1):38. PubMed ID: 35227274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognosis analysis of
    Zhang T; Zhao Y; Zhao Y; Zhou J
    Aging (Albany NY); 2020 Mar; 12(6):5031-5047. PubMed ID: 32209730
    [No Abstract]   [Full Text] [Related]  

  • 6. BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Xu ZJ; Gu Y; Ma JC; Li XX; Guo H; Wen XM; Zhang W; Yang L; Liu XH; Lin J; Qian J
    Diagn Pathol; 2019 Jun; 14(1):68. PubMed ID: 31253168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia.
    Chu MQ; Zhang TJ; Xu ZJ; Gu Y; Ma JC; Zhang W; Wen XM; Lin J; Qian J; Zhou JD
    J Cell Mol Med; 2020 Jan; 24(2):1640-1649. PubMed ID: 31794134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
    Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
    Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia.
    Han C; He S; Wang R; Gao X; Wang H; Qiao J; Meng X; Li Y; Yu L
    J Transl Med; 2021 Feb; 19(1):65. PubMed ID: 33579308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia.
    Hua S; Feng T; Yin L; Wang Q; Shao X
    J Cell Mol Med; 2021 Oct; 25(19):9331-9339. PubMed ID: 34432355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
    Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
    Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest China.
    Gao L; Wen Q; Chen X; Liu Y; Zhang C; Gao L; Kong P; Zhang Y; Li Y; Liu J; Wang Q; Su Y; Wang C; Wang S; Zeng Y; Sun A; Du X; Zeng D; Liu H; Peng X; Zhang X
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):1932-9. PubMed ID: 25109850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.
    Zhang G; Shi J; Yang X; Zhang X; Zhang L; Zhang J; Yang S; Wang J; Hu K; Ke X; Fu L
    Oncol Lett; 2019 Jun; 17(6):5815-5820. PubMed ID: 31186809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Cheng Z; Zhou L; Hu K; Dai Y; Pang Y; Zhao H; Wu S; Qin T; Han Y; Hu N; Chen L; Wang C; Zhang Y; Wu D; Ke X; Shi J; Fu L
    Bone Marrow Transplant; 2018 Sep; 53(9):1089-1095. PubMed ID: 29515250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Long Non-Coding RNA
    Shi J; Ding W; Lu H
    Onco Targets Ther; 2020; 13():8441-8450. PubMed ID: 32922034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
    Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
    J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
    Ardestani MT; Kazemi A; Chahardouli B; Mohammadi S; Nikbakht M; Rostami S; Jalili M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
    Turk J Haematol; 2018 Aug; 35(3):158-167. PubMed ID: 29786546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
    Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2020 Dec; 99(12):2911-2925. PubMed ID: 33000361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.